Spinal Implants – Market Insights – United States

The US spinal implant market is projected to grow steadily, despite being limited by declining ASPs. This growth will be supported by favorable demographic trends, such as an aging population, and the increasing demand for minimally invasive surgical techniques. Additionally, the market will benefit from higher implant sales driven by enabling technologies, the shift to outpatient procedures, and expanding insurance coverage for spinal nonfusion technologies. Advancements in implant materials and design, along with the integration of robotics and navigation systems in surgeries, will further enhance market demand.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for spinal implants in the US from 2019 through 2033.

Changes to product mix partially mitigate the negative effects of commoditization.

What innovations to the spinal implant market are growing in demand, opposing the declining aggregate prices?

How does the rise of minimally invasive spine procedures affect spinal implant ASPs?

Spinal nonfusion technologies are seeing the fastest growth.

Which product types within spinal nonfusion technologies are growing fastest?

Which commercial coverage trends will affect the market outlook?

How do prices evolve in the fastest growing product types?

Which new products have the potential to shape the market?

The gradual shift of spinal implant procedures to outpatient facilities and ASCs affects the entire spinal implant market.

Which procedures are most likely to be performed in an outpatient setting?

How does this migration to the outpatient setting affect procedure ASPs?

What are the advantages of outpatient facilities compared to inpatient facilities?

IBDs are becoming more prevalent in spinal fusion procedures.

What approaches are growing in popularity, and at what pace are they growing?

Which IBD innovations are gaining the most success in the US market?

Manufacturers are prioritizing spine surgical ecosystems to drive engagement with surgeons and promote implant sales.

Which manufacturers have matured enabling technologies and leveraged those devices to gain market share?

Which implant manufacturers have developed partnerships to close gaps with enabling technologies?

Many manufacturers have broadened their product portfolios by launching new implants or acquiring companies with complementary offerings.

Which competitors are using the breadth of their product portfolios to sustain or increase their spinal implants market shares?

How are competitors expanding their offerings through mergers, acquisitions, and/or partnerships to capture a larger share of the spinal implants market?